UTHR
United Therapeutics Corporation
Stock
$541.70−29.68 (−5.19%)Close Oct 2, 2026
- Net income, 2025
- $1.3B
- YoY, 2025
- +11.7%
- 5-year CAGR
- +21.0%
- 10-year CAGR
- +7.4%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $1.3B | +11.7% |
| 2024 | $1.2B | +21.4% |
| 2023 | $985M | +35.4% |
| 2022 | $727M | +52.9% |
| 2021 | $476M | −7.6% |
| 2020 | $515M | — |
| 2019 | −$105M | — |
| 2018 | $589M | +41.0% |
| 2017 | $418M | −41.4% |
| 2016 | $714M | +9.5% |
| 2015 | $652M | +91.6% |
| 2014 | $340M | +94.8% |
| 2013 | $175M | −42.7% |
| 2012 | $304M | +39.7% |
| 2011 | $218M | +105.7% |
| 2010 | $106M | +444.2% |
| 2009 | $19M | — |
| 2008 | −$49M | — |